Argus analysts David Toung and Marisa Janeczek raised their price target on AmerisourceBergen (ABC) to $115, saying the company's Q1 earnings were marked by "solid results in pharma distribution, specialty distribution, and consulting and logistics services". The analysts keeps their Buy rating on the stock, adding that despite the termination of merger talks with Walgreen Boots (WBA), there are strong growth opportunities for the stock as the company begins operations at six new distribution centers. Toung and Janeczek note that the 7% pullback in the stock price marks a favorable entry point.